Bristol-Myers Squibb Rights
CELG.RT
25 hedge funds and large institutions have $194K invested in Bristol-Myers Squibb Rights in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
7% less funds holding
Funds holding: 27 → 25 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
71% less capital inflows, than outflows
Capital inflows: $5.6K | Capital outflows: $19.3K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Private Advisor Group
Morristown,
New Jersey
|
+$5.46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8K |
| 3 |
Winslow Evans & Crocker
Boston,
Massachusetts
|
-$1K |
| 4 |
Selway Asset Management
|
-$255 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9 |
CELG.RT Hedge Fund Activity: Q4 2020 in Review
25 of the 5,679 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q4 2020, worth a combined $194K — down 35% from $299K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CELG.RT and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Private Advisor Group, adding an estimated $5.46K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $10K sold.
- 25 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q4 2020, down from 27 in Q3 2020.
- Funds reported $194K of Bristol-Myers Squibb Rights stock for Q4 2020, down 35% quarter-over-quarter.
- 1 fund opened new Bristol-Myers Squibb Rights positions in Q4 2020 and 3 closed out, a net change of -2 holders.
- The largest Bristol-Myers Squibb Rights buyer in Q4 2020 was Private Advisor Group, an estimated $5.46K added.
- The largest Bristol-Myers Squibb Rights seller in Q4 2020 was Susquehanna International Group, an estimated $10K sold.
Based on aggregated 13F filings for Q4 2020.